Եվրոպական Միություն - իտալերեն - EMA (European Medicines Agency)

novartis europharm limited  - alpelisib - neoplasie al seno - agenti antineoplastici - piqray è indicato in combinazione con fulvestrant per il trattamento di donne in postmenopausa e uomini, con recettore ormonale (hr)-positivo, human epidermal growth factor receptor 2 (her2)-negativo, localmente avanzato o metastatico cancro al seno con una mutazione pik3ca dopo progressione della malattia dopo terapia endocrina come monoterapia (vedere la sezione 5.

Եվրոպական Միություն - իտալերեն - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - pexidartinib - giant cell tumor of tendon sheath; synovitis, pigmented villonodular - agenti antineoplastici - treatment of tenosynovial giant cell tumour.

Եվրոպական Միություն - իտալերեն - EMA (European Medicines Agency)

roche registration gmbh  - pralsetinib - carcinoma, polmone non a piccole cellule - agenti antineoplastici - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.

Շվեյցարիա - իտալերեն - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - axitinibum - compresse rivestite con film - axitinibum 1 mg, cellulosum microcristallinum, lactosum monohydricum, carmellosum natricum conexum corresp. natrium 0.21 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, triacetinum, e 171, e 172 (rubrum), pro compresso obducto corresp. lactosum monohydricum 33.60 mg. - carcinoma a cellule renali - synthetika

Շվեյցարիա - իտալերեն - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - axitinibum - compresse rivestite con film - axitinibum 5 mg, cellulosum microcristallinum, lactosum monohydricum, carmellosum natricum conexum corresp. natrium 0.37 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, triacetinum, e 171, e 172 (rubrum), pro compresso obducto corresp. lactosum monohydricum 58.8 mg. - carcinoma a cellule renali - synthetika

Շվեյցարիա - իտալերեն - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - axitinibum - compresse rivestite con film - axitinibum 3 mg, cellulosum microcristallinum, lactosum monohydricum, carmellosum natricum conexum corresp. natrium 0.22 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, triacetinum, e 171, e 172 (rubrum), pro compresso obducto corresp. lactosum monohydricum 35.30 mg. - carcinoma a cellule renali - synthetika

Շվեյցարիա - իտալերեն - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - axitinibum - compresse rivestite con film - axitinibum 7 mg, cellulosum microcristallinum, lactosum monohydricum, carmellosum natricum conexum corresp. natrium 0.51 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, triacetinum, e 171, e 172 (rubrum), pro compresso obducto corresp. lactosum monohydricum 82.32 mg. - carcinoma a cellule renali - synthetika

Շվեյցարիա - իտալերեն - Swissmedic (Swiss Agency for Therapeutic Products)

astellas pharma ag - gilteritinibum - compresse rivestite con film - gilteritinibum 40 mg ut gilteritinibi hemifumaras, mannitolum, hydroxypropylcellulosum, hydroxypropylcellulosum substitutum humile, magnesii stearas, Überzug: hypromellosum, talcum, macrogolum 8000, e 171, e 172 (flavum), pro compresso obducto. - akute myeloide leukämie (aml) - synthetika